» Articles » PMID: 37736586

Elevated BMPR2 Expression Amplifies Osteoblast Differentiation in Ankylosing Spondylitis

Overview
Journal J Rheum Dis
Specialty Rheumatology
Date 2023 Sep 22
PMID 37736586
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Bone morphogenetic protein receptor type 2 (BMPR2) has been associated with radiographic changes in ankylosing spondylitis (AS), but further characterization of the cellular signaling pathway in osteoprogenitor (OP) is not clearly understood. The aim of this study was to investigate the expression of BMPR2 and bone morphogenetic protein 2 (BMP2)-mediated responsibility in AS.

Methods: We collected 10 healthy control (HC) and 14 AS-OPs derived from facet joints. Subsequently, we then conducted RNA sequencing with two samples per group and selected BMP-related genes. Facet joint tissues and derived primary OPs were evaluated by validation of selected RNA sequencing data, immunohistochemistry, and comparison of osteogenic differentiation potential.

Results: Based on RNA-sequencing analysis, we found that BMPR2 expression is higher in AS-OPs compared to in HC-OPs. We also validated the increased BMPR2 expression in facet joint tissues with AS and its derived OPs in messenger RNA and protein levels. Additionally, primary AS-OPs showed much greater response to osteogenic differentiation induced by BMP2 and a higher capacity for smad1/5/8-induced RUNX2 expression compared to HCs.

Conclusion: The expression of BMPR2 was found to be significantly increased in facet joint tissues of patients with AS. These findings suggest that BMPR2 may play a role in the BMP2-mediated progression of AS.

Citing Articles

Targeting osteoclast-derived DPP4 alleviates inflammation-mediated ectopic bone formation in ankylosing spondylitis.

Lee S, Lee K, Kim D, Jeon C, Whangbo M, Jo H Arthritis Res Ther. 2025; 27(1):40.

PMID: 40001226 PMC: 11853818. DOI: 10.1186/s13075-025-03474-2.


Wnt5a exacerbates pathological bone features and trabecular bone loss in curdlan-injected SKG mice via osteoclast activation.

Whangbo M, Ko E, Kim D, Jeon C, Jo H, Lee S BMB Rep. 2024; 58(2):75-81.

PMID: 39681409 PMC: 11875747.


Voluntary exercise in mice triggers an anti-osteogenic and pro-tenogenic response in the ankle joint without affecting long bones.

Briolay A, Duboeuf F, Delplace S, Brizuela L, Peyruchaud O, Magne D Bone Rep. 2024; 23:101810.

PMID: 39493871 PMC: 11530850. DOI: 10.1016/j.bonr.2024.101810.

References
1.
Carter S, Braem K, Lories R . The role of bone morphogenetic proteins in ankylosing spondylitis. Ther Adv Musculoskelet Dis. 2012; 4(4):293-9. PMC: 3403253. DOI: 10.1177/1759720X12444175. View

2.
Lim K, Park N, Che X, Han M, Jeong J, Kim S . Core binding factor β of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice. J Bone Miner Res. 2014; 30(4):715-22. PMC: 7363154. DOI: 10.1002/jbmr.2397. View

3.
Park M, Park Y, Lee S . Relationship of bone morphogenetic proteins to disease activity and radiographic damage in patients with ankylosing spondylitis. Scand J Rheumatol. 2008; 37(3):200-4. DOI: 10.1080/03009740701774941. View

4.
Lories R, Derese I, Luyten F . Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest. 2005; 115(6):1571-9. PMC: 1090472. DOI: 10.1172/JCI23738. View

5.
Karim M, Madamanchi A, Dutko J, Mullins M, Umulis D . Heterodimer-heterotetramer formation mediates enhanced sensor activity in a biophysical model for BMP signaling. PLoS Comput Biol. 2021; 17(9):e1009422. PMC: 8509922. DOI: 10.1371/journal.pcbi.1009422. View